YORK, UK, 9 November 2005 -- Based on its extensive database of deals and financing information, Pharmalicensing has created a summary overview of deals data from 2004 for 50 of the world’s top pharmaceutical and biotechnology companies. The Top 50 Deals Briefing covers the whole of 2004, and is a concise rundown of the number of announced deals, the highest announced deal value and the most active deal stages and therapeutic areas for each of the top 50 companies, and includes the changes in levels of dealmaking between 2003 and 2004. The Partneringdesk team has collected details on around 17,000 deals from January 2000 to the present day. The Top 50 Deals Briefing is available free from www.partneringdesk.com.
